Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: Exploratory analysis of a placebo-controlled trial of atomoxetine

Current Medical Research and Opinion

Volumn 27, Issue 12, 2011, Pages 2309-2320

  Wilens, Timothy E ^a   Adler, Lenard A ^b   Tanaka, Yoko ^c   Xiao, Feng ^d   D'Souza, Deborah N ^d   Gutkin, Stephen W ^e   Upadhyaya, Himanshu P ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d i3 Statprobe   (United States)

^e Rete Biomedical Communications Corp   (United States)

Author keywords

Adult; Alcohol; Atomoxetine; Attention deficit hyperactivity disorder; Drug therapy; Treatment outcomes

Indexed keywords

ATOMOXETINE; PLACEBO;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; AGED; ALCOHOL DRINKING; ALCOHOL-INDUCED DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DOUBLE-BLIND METHOD; ETHANOL; FEMALE; HUMANS; MIDDLE AGED; PROPYLAMINES; TIME FACTORS;

EID: 81855184887     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.628648     Document Type: Article

References (76)

1. Barkley RA, Fischer M, Smallish L, et al. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 2006;45:192-202
2. Wilens TE, Dodson W. A clinical perspective of attention-deficit/ hyperactivity disorder into adulthood. J Clin Psychiatry 2004;65:1301-13
3. Mannuzza S, Klein RG, Bonagura N, et al. Hyperactive boys almost grown up. V. Replication of psychiatric status. Arch Gen Psychiatry 1991;48:77-83
4. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:1792-8
5. McGough JJ, Smalley SL, McCracken JT, et al. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry 2005;162:1621-7
6. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-23
7. Ohlmeier MD, Peters K, Te Wildt BT, et al. Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD). Alcohol Alcohol 2008;43:300-4
8. Biederman J, Wilens T, Mick E, et al. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995;152:1652-8
9. Disney ER, Elkins IJ, McGue M, Iacono WG. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. Am J Psychiatry 1999;156:1515-21
10. Wilens TE, Biederman J, Mick E, et al. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis 1997;185:475-82
11. Schubiner H, Tzelepis A, Milberger S, et al. Prevalence of attention-deficit/ hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry 2000;61:244-51
12. Kalpag AS, Levin FR. Adult ADHD and substance abuse: diagnostic and treatment issues. Substance Use Misuse 2005;40:13-14
13. Wilens TE. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am 2004;27:283-301
14. Wilens TE. Attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry 2006;163:2059-63
15. Carroll KM, Rounsaville BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 1993;34:75-82
16. Wilens TE, Biederman J, Mick E. Does ADHD affect the course of substance abuse?. Findings from a sample of adults with and without ADHD. Am J Addict 1998;7:156-63
17. Adler LA, Guida F, Irons S, et al. Open label pilot study of atomoxetine in adults with ADHD and substance use disorder. J Dual Diagn 2010;6:196-207
18. Schubiner H, Saules KK, Arfken CL, et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 2002;10:286-94
19. Levin FR, Evans SM, Brooks DJ, et al. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend 2006;81:137-48
20. Levin FR, Evans SM, Brooks DJ, et al. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend 2007;87:20-9
21. Levin FR, Mariani JJ, Secora A, et al. Atomoxetine treatment for cocaine abuse and adult attention-deficit hyperactivity disorder (ADHD): a preliminary open trial. J Dual Diagn 2009;5:41-56
22. Carpentier PJ, de Jong CA, Dijkstra BA, et al. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Addiction 2005;100:1868-74
23. Upadhyaya HP, Brady KT, Sethuraman G, et al. Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol 2001;21:116-18
24. Wilens TE, Adler LA, Weiss MD, et al. Atomoxetine ADHD/SUD Study Group. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend 2008;96:145-54
25. Adler L, Wilens T, Zhang S, et al. Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence. Am J Addict 2009;18:393-401
26. Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003;53:112-20
27. US Department of Health and Human Services, US Department of Agriculture. Dietary Guidelines for Americans, 6th edn. Washington, DC: US Government Printing Office, 2005
28. Borges G, Cherpitel CJ, Mondragón L, et al. Episodic alcohol use and risk of nonfatal injury. Am J Epidemiol 2004;159:565-71
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, 4th edition text revision. Washington, DC: American Psychiatric Association, 2000
30. Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/ hyperactivity disorder. Psychiatr Clin North Am 2004;27:187-201
31. Adler L, Spencer T. The Adult ADHD Clinical Diagnostic Scale (ACDS) V 1.2. New York: New York University School of Medicine, 2004
32. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96
33. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
34. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5
35. Romera I, Perez V, Menchon JM, et al. Optimal cutoff point of the Hamilton Rating Scale for Depression according to normal levels of social and occupational functioning. Psychiatry Res 2011;186:133-7
36. Vaccarino AL, Evans KR, Sills TL, Kalali AH. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression. Depress Anxiety 2008;25:1006-13
37. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV TR Axis I Disorders, Research Edition, Patient Version (SCIDI/P). New York, NY: Biometrics Research Dept., New York State Psychiatric Institute, 2002
38. World Medical Association. Declaration of Helsinki: Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects, 5th revision. 2000
39. Spencer TJ, Adler LA, Qiao M, et al. Validation of the adult ADHD investigator symptom rating scale (AISRS). J Atten Disord 2010;14:57-68
40. Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005;35:245-56
41. Sobell LC, Sobell MB. Timeline followback: a technique for assessing selfreported alcohol consumption. In: Allen J, Litten R (eds.) Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Totowa, NJ: Humana Press, 1992:41-72
42. Anton RF, Moak D, Latham PK. The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 1996;53:225-31
43. Anton RF. Obsessive-compulsive aspects of craving: development of the Obsessive Compulsive Drinking Scale. Addiction 2000;95(Suppl 2):S211-17
44. Anton RF, Moak DH, Latham P. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res 1995;19:92-9
45. Bohn MJ, Barton BA, Barron KE. Psychometric properties and validity of the obsessive-compulsive drinking scale. Alcohol Clin Exp Res 1996;20:817-23
46. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990;9:811-18
47. Hopkins K, Glass GV. Statistical Methods in Education and Psychology, 3rd edn. Columbus, OH: Pearson Allyn & Bacon, 1995
48. Weafer J, Camarillo D, Fillmore MT, et al. Simulated driving performance of adults with ADHD: comparisons with alcohol intoxication. Exp Clin Psychopharmacol 2008;16:251-63
49. Saylor K, Williams DW, Schuh KJ, et al. Effects of atomoxetine on selfreported high-risk behaviors and health-related quality of life in adolescents with ADHD. Curr Med Res Opin 2010;26:2087-95
50. Thurstone C, Riggs PD, Salomonsen-Sautel S, et al. Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. J Am Acad Child Adolesc Psychiatry 2010;49:573-82
51. Riggs PD. Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry 1998;37:331-2
52. Wilens TE. The nature of the relationship between attention-deficit/ hyperactivity disorder and substance use. J Clin Psychiatry 2007;68 (Suppl 11):4-8
53. Anton RF, O'Malley SS, Ciraulo DA, et al. COMBINE Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006;295: 2003-17
54. Levin FR, Evans SM, McDowell DM, Kleber HD. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry 1998;59:300-5
55. Riggs PD, Leon SL, Mikulich SK, Pottle LC. An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry 1998;37:1271-8
56. Weafer J, Filmore MT, Milich R. Increased sensitivity to the disinhibiting effects of alcohol in adults with ADHD. Exp Clin Psychopharmacol 2009;17: 113-21
57. Knop J, Penick EC, Nickel EJ, et al. Childhood ADHD and conduct disorder as independent predictors of male alcohol dependence at age 40. J Stud Alcohol Drugs 2009;70:169-77
58. Lopez B, Schwartz SJ, Prado G, et al. Correlates of early alcohol and drug use in Hispanic adolescents: examining the role of ADHD with comorbid conduct disorder, family, school, and peers. J Clin Child Adolesc Psychol 2008;37: 820-32
59. Ohlmeier MD, Peters K, Kordon A, et al. Nicotine and alcohol dependence in patients with comorbid attention-deficit/hyperactivity disorder (ADHD). Alcohol Alcohol 2007;42:539-43
60. Comings DE. Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. II. Alcohol abuse. Drug Alcohol Depend 1994;35:17-24
61. Field M, Duka T. Cues paired with a low dose of alcohol acquire conditioned incentive properties in social drinkers. Psychopharmacology (Berl) 2002;159: 325-34
62. Sharma D, Albery IP, Cook C. Selective attentional bias to alcohol related stimuli in problem drinkers and non-problem drinkers. Addiction 2001;96: 285-95
63. Townshend JM, Duka T. Patterns of alcohol drinking in a population of young social drinkers: a comparison of questionnaires and diary measures. Alcohol Alcohol 2002;37:187-92
64. Abroms BD, Gottlob LR, Filmore MT. Alcohol effects on inhibitory control of attention: distinguishing between intentional and automatic mechanisms. Psychopharmacology (Berl) 2006;188:324-34
65. Barkley RA, Murphy KR, O'Connell T, et al. Effects of two doses of alcohol on simulator driving performance in adults with attention-deficit/ hyperactivity disorder. Neuropsychology 2006;20:77-87
66. Biederman J, Wilens T, Mick E, et al. Is ADHD a risk factor for psychoactive substance use disorders?. Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1997;36:21-9
67. Schatz DB, Rostain AL. ADHD with comorbid anxiety: a review of the current literature. J Atten Disord 2006;10:141-9
68. Kunwar A, Dewan M, Faraone SV. Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder. Expert Opin Pharmacother 2007;8:555-62
69. Wilens TE, Biederman J, Faraone SV, et al. Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. J Clin Psychiatry 2009;70:1557-62
70. Mariani JJ, Levin FR. Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict 2007;16(Suppl 1):45-54
71. Schubiner H, Tzelepis A, Isaacson JH, et al. The dual diagnosis of attentiondeficit/ hyperactivity disorder and substance abuse: case reports and literature review. J Clin Psychiatry 1995;56:146-50
72. Vitiello B. Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2001;11:25-34
73. Wilens TE, Adler LA, Adams J, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 2008;47:21-31
74. Caetano R, Tam T, Greenfield T, et al. DSM-IV alcohol dependence and drinking in the U.S. population: a risk analysis. Ann Epidemiol 1997;7:542-9
75. Dickson RA, Maki E, Gibbins C, et al. Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/ hyperactivity disorder: analysis of Canadian open-label studies. Child Adolesc Psychiatry Ment Health 2011;5:14
76. Steele M, Jensen PS, Quinn DM. Remission versus response as the goal of therapy in ADHD: a new standard for the field?. Clin Ther 2006;28:1892-908